Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy

Pediatric Blood and Cancer

Volumn 48, Issue 3, 2007, Pages 330-332

  Jones, Emma ^a   Koyama, Tatsuki ^a   Ho, Richard H ^a   Kuttesch, John ^a   Shankar, Sadhna ^a   Whitlock, James A ^a   Cartwright, Julia ^a   Frangoul, Haydar ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Antiemetic; Chemotherapy; Nausea and vomiting

Indexed keywords

DEXAMETHASONE; DIPHENHYDRAMINE; DOLASETRON MESILATE; GRANISETRON; LORAZEPAM; ONDANSETRON;

ADOLESCENT; ADULT; AGITATION; ARTICLE; CANCER THERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONFUSION; CONTINUOUS INFUSION; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DYSPHORIA; FEMALE; HUMAN; INFUSION PUMP; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTLESSNESS; SCHOOL CHILD; SIDE EFFECT;

ADOLESCENT; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CONFUSION; DEXAMETHASONE; DIPHENHYDRAMINE; DRUG THERAPY, COMBINATION; FEMALE; GRANISETRON; HUMANS; INDOLES; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; LORAZEPAM; MALE; MOOD DISORDERS; ONDANSETRON; PATIENT ACCEPTANCE OF HEALTH CARE; QUINOLIZINES; RECEPTORS, SEROTONIN, 5-HT3; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 33846905242     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20711     Document Type: Article

References (15)

1. De Boer-Dennert M, de Wit R, Schmitz PI, et al. Patient perceptions of the side-effects of chemotherapy: The influence of 5HT3 antagonists. Br J Cancer 1997;76:1055-1061.
2. Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996;7:189-195.
3. Small BE, Holdsworth MT, Raisch DW, et al. Survey ranking of emetogenic control in children receiving chemotherapy. J Pediatr Hematol Oncol 200;22:125-132.
4. Hesketh PJ, Kris MG, Grunberg SM, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15:103-109.
5. Adis International Ltd. Ondansetron a good choice amoung front-line antiemetics for children undergoing chemotherapy, radiotherapy, and surgery. Drug Ther Perspect 2002;18:1-4.
6. Hewitt M, McQuade B, Stevens R. The efficacy and safety of ondansetron in the prophylaxis of cancer-chemotherapy induced nausea and vomiting in children. Clin Oncol 1993;5:11-14.
7. Jurgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy induced emesis in children. Oncology 1992;49:279-285.
8. Kolecki P, Wachowiak J, Beshari SE. Ondansetron as an effective drug in prophylaxis of chemotherapy-induced emesis in children. Acta Haematol Pol 1993;24:115-122.
9. Alvarez O, Freeman A, Bedros A, et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 1995;17:145-150.
10. Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines. J Clin Oncol 1999;17:2971-2994.
11. Roila F, Aapro M, Stewart A. Optimal selection of antiemetics in children receiving cancer chemotherapy. Supp Care Canc 1998; 6:215-220.
12. Antonarakis E, Evans J, Heard G, et al. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: What is the evidence? Pediatr Blood Cancer 2004; 43: 651-658.
13. Ripamonti C, Bruera E. Current status of patient-controlled analgesia in cancer patients. Oncology 1997;11: 373-80, 383-384.
14. Mackie AM, Coda BC, Hill HF. Adolescents use patient-controlled analgesia effectively for relief from prolonged oropharyngeal mucositis pain. Pain 1991;46:265-269.
15. Dix SP, Cord MK, Howard SJ, et al. Safety and efficacy of a continous infusion, patient controlled antiemetic pump to facilitate outpatient administration of high dose chemotherapy. Bone Marrow Transplant 1999;24:561-566.